Survival After Fertility-Sparing Surgery for Early-Stage Cervical Cancer Compared With Nonsparing Surgery: A Nationwide Comparative Study

作者
Janneke T. Wolswinkel,Petra L.M. Zusterzeel,Anke Smits,Albert G. Siebers,Hans H.B. Wenzel,Ruud L.M. Bekkers,Jogchum Beltman,Christianne Lok,Constantijne H. Mom,Nienke E. van Trommel,Ronald P. Zweemer,Jake S.F. Maurits,Mieke Ten Eikelder
出处
期刊:JCO oncology practice [Lippincott Williams & Wilkins]
卷期号:: OP2500131-OP2500131
标识
DOI:10.1200/op-25-00131
摘要

PURPOSE The oncologic safety of fertility-sparing surgery in young women with early-stage cervical cancer is largely based on retrospective data from small series, highlighting the need for larger studies to validate its safety. METHODS We performed a nation-wide retrospective matched cohort study of all patients age 18-45 years with Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) 2018 stage IA1 to IB2 cervical cancer who underwent fertility-sparing surgery (FSS; cone biopsy, large loop excision of the transformation zone, or [radical] trachelectomy) between 2000 and 2022 in the Netherlands (fertility-sparing group). These patients were matched 1:2 with women who had a (radical) hysterectomy for early-stage cervical cancer (hysterectomy group). Patients were matched for pretreatment FIGO 2018 stage, histology, and lymph vascular space invasion. We compared data on recurrence-free survival, disease-free survival, and overall survival (OS) between the fertility-sparing group and the hysterectomy-group. RESULTS In total, 1,446 patients were included: 482 treated with FSS and 964 with a (radical) hysterectomy; 57.5% had stage 1A1 or 1A2, and 42.5% had IB1 or IB2 cervical cancer. The median follow-up was 8.9 years (IQR, 4.4-13.7). During the study period, 4.8% of patients developed a recurrence: 7.1% in the fertility-sparing group and 3.6% in the hysterectomy group (hazard ratio [HR], 2.21 [95% CI, 1.38 to 3.56]).The OS in both groups did not differ (HR, 1.06 [95% CI, 0.62 to 1.80]). CONCLUSION Women treated with FSS had a significantly higher recurrence rate than patients who had the uterus completely removed. However, since the increased recurrence rate did not affect OS, fertility-sparing surgery appears to be a potentially safe treatment option.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇的应助被pp采纳,获得10
1秒前
1秒前
火星上的小虾米完成签到,获得积分10
1秒前
励志发SCI发布了新的文献求助20
1秒前
简单灵凡发布了新的文献求助10
1秒前
科研通AI6.3的应助被吃的采纳,获得10
3秒前
3秒前
Nancy完成签到,获得积分10
4秒前
楚明允完成签到 ,获得积分10
5秒前
自信谷冬发布了新的文献求助10
6秒前
甜美的雪冥完成签到,获得积分10
7秒前
ztt发布了新的文献求助10
7秒前
8秒前
8秒前
orixero的应助被开心德地采纳,获得10
10秒前
chengxue发布了新的文献求助10
11秒前
justonce发布了新的文献求助10
11秒前
11秒前
12秒前
12秒前
conniechen完成签到,获得积分10
12秒前
Jasper的应助被科研通管家采纳,获得10
13秒前
13秒前
领导范儿的应助被科研通管家采纳,获得10
13秒前
科研通AI65的应助被科研通管家采纳,获得10
13秒前
Miu的应助被科研通管家采纳,获得10
13秒前
Orange的应助被科研通管家采纳,获得10
13秒前
bkagyin的应助被科研通管家采纳,获得10
13秒前
秋风的应助被科研通管家采纳,获得10
13秒前
李爱国的应助被科研通管家采纳,获得10
14秒前
Youdge的应助被科研通管家采纳,获得20
14秒前
科研通AI2S的应助被科研通管家采纳,获得10
14秒前
SciGPT的应助被科研通管家采纳,获得10
14秒前
烟花的应助被科研通管家采纳,获得10
14秒前
hunter完成签到 ,获得积分10
14秒前
小春卷完成签到,获得积分10
14秒前
CodeCraft的应助被科研通管家采纳,获得10
14秒前
无花果的应助被科研通管家采纳,获得10
15秒前
搜集达人的应助被科研通管家采纳,获得10
15秒前
syvshc的应助被科研通管家采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188634
求助须知:如何正确求助?哪些是违规求助? 9576342
关于积分的说明 21847026
捐赠科研通 7786653
什么是DOI,文献DOI怎么找? 3435402
关于科研通互助平台的介绍 2559632
邀请新用户注册赠送积分活动 2482360